Abstract 3845: Antitumor activity of SEL120: An orally available dual inhibitors of Haspin/CDK9, for standalone and combination therapy with AuroraB inhibitors in solid tumors and hematopoietic malignanciesTomasz Rzymski, Nicolas Beuzen, Agnieszka Kłosowska‐Wardęga et al.|Cancer Research|2012Cited by 3
Abstract B242: Antitumor activity of SEL120: An orally available small-molecule inhibitor of Haspin kinase for standalone and combination therapy with AuroraB inhibitors in colorectal cancer.Tomasz Rzymski, Krzysztof Brzózka, Adrian Zarębski et al.|Molecular Cancer Therapeutics|2011Cited by 0